Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

BACKGROUND: The survival benefit for single-agent anti–epidermal growth factor receptor (egfr) therapy compared with combination therapy with irinotecan in KRAS wildtype (wt) metastatic colorectal cancer (mcrc) patients in the third-line treatment setting is not known. The objective of the present s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kennecke, H., Chen, L., Blanke, C.D., Cheung, W.Y., Schaff, K., Speers, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3851344/
https://ncbi.nlm.nih.gov/pubmed/24311948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados